標題: Titlebook: Artificial Intelligence and Precision Oncology; Bridging Cancer Rese Zodwa Dlamini Book 2023 The Editor(s) (if applicable) and The Author(s [打印本頁] 作者: 熱愛 時間: 2025-3-21 19:34
書目名稱Artificial Intelligence and Precision Oncology影響因子(影響力)
書目名稱Artificial Intelligence and Precision Oncology影響因子(影響力)學科排名
書目名稱Artificial Intelligence and Precision Oncology網(wǎng)絡(luò)公開度
書目名稱Artificial Intelligence and Precision Oncology網(wǎng)絡(luò)公開度學科排名
書目名稱Artificial Intelligence and Precision Oncology被引頻次
書目名稱Artificial Intelligence and Precision Oncology被引頻次學科排名
書目名稱Artificial Intelligence and Precision Oncology年度引用
書目名稱Artificial Intelligence and Precision Oncology年度引用學科排名
書目名稱Artificial Intelligence and Precision Oncology讀者反饋
書目名稱Artificial Intelligence and Precision Oncology讀者反饋學科排名
作者: 創(chuàng)新 時間: 2025-3-21 21:52
978-3-031-21508-7The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: Postulate 時間: 2025-3-22 01:19 作者: 細頸瓶 時間: 2025-3-22 08:04
http://image.papertrans.cn/b/image/162265.jpg作者: 表示問 時間: 2025-3-22 12:00
https://doi.org/10.1007/3-540-29873-8oring to an individual patient or group of patients would vastly decrease the burden of cancer while ensuring higher rates of patient survival and treatments with less side effects and more success in controlling or eliminating the disease. Precision oncology requires that as much information regard作者: arthroplasty 時間: 2025-3-22 12:54 作者: 不利 時間: 2025-3-22 20:29
https://doi.org/10.1007/3-540-29873-8urrent challenges in cancer treatment include the shortage of expertise, delay in diagnosis, inaccurate quantitative staging and variable treatment response. An improvement in the understanding of the pathogenesis of cancer, tumour microenvironment and metastatic pathways has led to an increase in t作者: 招致 時間: 2025-3-22 22:01 作者: Confirm 時間: 2025-3-23 04:06
https://doi.org/10.1007/3-540-29873-8 prognosis, and treatment. Personalized medicine requires key features to be extracted from large data sets, normally using artificial intelligence (AI). Artificial intelligence can also be used to perform digital pathology and to identify key features in cytology, hematology, and histology based on作者: 合同 時間: 2025-3-23 08:39
https://doi.org/10.1007/3-540-29873-8iptome and proteomic profiles that are unique or more common in cancer. However, it has become obvious that for complex diseases like cancer, it is important and incredibly useful to examine the genetic changes that occur to alter gene expression that do not rely on changes to the genetic sequence. 作者: Compatriot 時間: 2025-3-23 10:32
Klassischer Frosch und Urfrosch im Vergleichof precision medicine. Despite its enormous potential that has already been explored widely, metabolomics has been relatively underutilized in all other sectors and so much so in oncology. Metabolites have been used in the recent past to diagnose complex metabolic diseases including disorders such a作者: intolerance 時間: 2025-3-23 14:46
Bioequivalence: Modeling and Simulation,rties, at a specific time. Because of the sheer number of micro-organisms occupying the human body the microbiome offers substantially more genetic diversity, and hence more flexibility, than the human genome..Disturbances in the microbiome have been linked to the development of various diseases inc作者: 滔滔不絕地講 時間: 2025-3-23 19:58
https://doi.org/10.1007/978-3-030-04462-6ctice and is incorporated into diagnosis and treatment to manage different medical conditions. Precision medicine or personalized medicine aims at individualizing treatment for patients to overcome general treatment that works for some patients. For other patients, the treatment is ineffective or ma作者: 遭遇 時間: 2025-3-23 23:49
Gerald B. Halt,John C. Donch,Dana L. Bluehese devices are by their very nature a form of personalised medicine as they analyse data recorded from individual patients. They may take the form of an actual recording device with AI built-in or merely as a software that can be loaded onto a variety of devices or even operated remotely from the 作者: 險代理人 時間: 2025-3-24 06:21 作者: Sciatica 時間: 2025-3-24 09:45
FDA Meetings and Device Testing. Artificial intelligence has been imperative in the screening and detection of cancer for decades. As technology evolves, AI has gone as far as predicting the risk of cancer development or recurrence. More profoundly, machine learning (ML) can advance individualized cancer therapy (precision medici作者: 參考書目 時間: 2025-3-24 12:22
FDG PET/CT in Clinical Oncologyare not meant to replace human capabilities, its benefits cannot be ignored either, as humans’ capacity to generate most appropriate personalised treatment may be limited. Every patient responds uniquely to treatment and AI-tools offer opportunities to study unique mechanisms of response and even re作者: Exhilarate 時間: 2025-3-24 17:16
FDG PET/CT in Clinical Oncologylls, judgements and experience. AI-Pathway companion is now the foundation of precision medicine and provides advanced analytics to manage the vast amount of data. In the past, practising medicine was focused on general solutions that allow safe treatments of most patients with similar symptoms. Thu作者: 討好美人 時間: 2025-3-24 19:50 作者: HILAR 時間: 2025-3-24 23:11 作者: 枕墊 時間: 2025-3-25 06:45 作者: multiply 時間: 2025-3-25 10:23 作者: NOT 時間: 2025-3-25 15:42 作者: HAUNT 時間: 2025-3-25 18:27
AI as a Novel Approach for Exploring ccfNAs in Personalized Clinical Diagnosis and Prognosis: Providon that considers the differences in individuals’ genes and lifestyles. The purpose of precision medicine is to provide patient-specific treatments at the right time for quick and cost-effective recovery. While world technological advances provide the opportunity for many in medical science to acces作者: 吝嗇性 時間: 2025-3-25 21:26
AI-Enhanced Digital Pathology and Radiogenomics in Precision Oncology prognosis, and treatment. Personalized medicine requires key features to be extracted from large data sets, normally using artificial intelligence (AI). Artificial intelligence can also be used to perform digital pathology and to identify key features in cytology, hematology, and histology based on作者: encyclopedia 時間: 2025-3-26 04:00 作者: Intact 時間: 2025-3-26 04:25
Association of Metabolomics with AI in Precision Oncology: Emerging Perspectives for More Effective of precision medicine. Despite its enormous potential that has already been explored widely, metabolomics has been relatively underutilized in all other sectors and so much so in oncology. Metabolites have been used in the recent past to diagnose complex metabolic diseases including disorders such a作者: Genteel 時間: 2025-3-26 11:33 作者: 膽汁 時間: 2025-3-26 14:15
AI and Nanomedicine in Realizing the Goal of Precision Medicine: Tailoring the Best Treatment for Pectice and is incorporated into diagnosis and treatment to manage different medical conditions. Precision medicine or personalized medicine aims at individualizing treatment for patients to overcome general treatment that works for some patients. For other patients, the treatment is ineffective or ma作者: 杠桿 時間: 2025-3-26 18:59 作者: Indolent 時間: 2025-3-26 23:01 作者: TRUST 時間: 2025-3-27 02:47
Applying Artificial Intelligence Prediction Tools for Advancing Precision Oncology in Immunotherapy:. Artificial intelligence has been imperative in the screening and detection of cancer for decades. As technology evolves, AI has gone as far as predicting the risk of cancer development or recurrence. More profoundly, machine learning (ML) can advance individualized cancer therapy (precision medici作者: Bridle 時間: 2025-3-27 05:39
Employing AI-Powered Decision Support Systems in Recommending the Most Effective Therapeutic Approacare not meant to replace human capabilities, its benefits cannot be ignored either, as humans’ capacity to generate most appropriate personalised treatment may be limited. Every patient responds uniquely to treatment and AI-tools offer opportunities to study unique mechanisms of response and even re作者: 只有 時間: 2025-3-27 11:12 作者: stroke 時間: 2025-3-27 16:15 作者: 籠子 時間: 2025-3-27 20:45
Conclusion and Insights into the Future of AI in Precision Oncologyis, prognosis, treatment, and survival. Artificial intelligence (AI) is fast changing how medical research is done with resultant improvements in patient care. By analyzing large data sets, AI allows for the prediction of disease risk, early detection of disease progression, and treatment outcomes f作者: 精美食品 時間: 2025-3-27 23:57
https://doi.org/10.1007/978-3-030-04462-6cording to their genetic profiles, however there are still some limitations to these technologies. This chapter will examine the role of Artificial Intelligence (AI) and nanotechnology integration in realizing the goal of precision medicine.作者: 終止 時間: 2025-3-28 03:30
https://doi.org/10.1007/978-3-030-04462-6he splicing pathway, AI can improve this by helping screen proteome and transcriptome databases to identify new splice variants. AI can also model the three-dimensional structure of new isoforms in order to screen for compounds that can bind exclusively to these isoforms.作者: 同位素 時間: 2025-3-28 07:40 作者: indigenous 時間: 2025-3-28 13:06 作者: cleaver 時間: 2025-3-28 14:40 作者: DAMN 時間: 2025-3-28 19:14 作者: 水汽 時間: 2025-3-29 02:17 作者: Blemish 時間: 2025-3-29 05:28
Book 2023sis, prognosis and treatment. Precision oncology has long been thought of as ideal for the management and treatment of cancer. This strategy promises to revolutionize the treatment, control, and prevention of cancer by tailoring tests, treatments and predictions to specific individuals or population作者: 厭食癥 時間: 2025-3-29 09:24
Book 2023chieved through the use of AI...The book is divided into three parts starting with a section on the use of artificial intelligence for screening, diagnosis and monitoring in precision oncology. The second part: Artificial intelligence and Omics in precision oncology, highlights the use of AI and epi作者: 冰河期 時間: 2025-3-29 12:50
on on the use of artificial intelligence for screening, diagnosis and monitoring in precision oncology. The second part: Artificial intelligence and Omics in precision oncology, highlights the use of AI and epi978-3-031-21508-7978-3-031-21506-3作者: Nonthreatening 時間: 2025-3-29 16:30
The Application of AI in Precision Oncology: Tailoring Diagnosis, Treatment, and the Monitoring of deal technology to manage and interpret these large datasets. In conjunction with machine learning (ML) and deep learning (DL), AI can more accurately interpret not only omics data, but it can also integrate data from other sources such as patient reports and medical imaging to give a more precise v作者: 真繁榮 時間: 2025-3-29 20:36 作者: probate 時間: 2025-3-30 00:54 作者: 油氈 時間: 2025-3-30 04:34 作者: HPA533 時間: 2025-3-30 11:14 作者: Ardent 時間: 2025-3-30 14:11 作者: Mortar 時間: 2025-3-30 20:32 作者: granite 時間: 2025-3-30 21:43 作者: buoyant 時間: 2025-3-31 02:39 作者: CHART 時間: 2025-3-31 06:14
Employing AI-Powered Decision Support Systems in Recommending the Most Effective Therapeutic Approacy transform the landscape of precision oncology in favour of improved patient outcome. This chapter will focus on AI-enhanced decision support systems in optimising therapeutic approaches, advancing precision oncology and improving patient outcome.
